Preclinical Studies Demonstrate Durable Protection Against SARS-CoV-2 Variants, Including Omicron XBB.1.5, Driven by T-Cell Responses  ATLANTA, GA - June 9, 2025 (NEWMEDIAWIRE) - GeoVax Labs, Inc.

GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing multi-antigen vaccines and immunotherapies, today announced that company representatives will attend the 2025 BIO ...

GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing multi-antigen vaccines and immunotherapies, today issued a statement in response to the World Health Organization’s ...

Data from Two Key Studies Highlight CrossReactivity and BroadSpectrum Immunity of GEO-CM04S1 and GeoVax Multi-Antigen Vaccine ...

Data from Two Key Studies Highlight Cross-Reactivity and Broad-Spectrum Immunity of GEO-CM04S1 and GeoVax Multi-Antigen Vaccine Technology "These presentations underscore our commitment to ...

ATLANTA, GA - May 27, 2025 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing multi-antigen vaccines and immunotherapies, today announced its ...

GeoVax Labs, Inc. WT EXP 092925 SEC Filing - Annual Report (10-K) March 27, 2025 SEC Filings Thu, Mar. 27 GeoVax Labs, Inc. (GOVX) Q3 2024 Earnings Call Transcript ...

GeoVax Labs, Inc. (NASDAQ:GOVX) Q3 2024 Earnings Call Transcript November 12, 2024 Operator: Good afternoon and welcome everyone to the GeoVax Third Quarter 2024 Corporate Update Call. My name is ...

Shares of GeoVax Labs Inc. ($GOVX), SIGA Technologies Inc. ($SIGA), and Emergent Biosolutions Inc. ($EBS) gained in mid-day trading on Friday after the World Health ...

No significant news for GOVXW in the past two years. Key Stock Data P/E Ratio (TTM) The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent ...

Access GeoVax Labs stock price history with daily data, historical prices, all-time highs, and stock chart history. Download and analyze trends easily.